Xiyu Li

Dr. Xiyu Li

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2021 in Comprehensive Reviews in Food Science and Food Safety
Verified
Journal Article
Open access
PDF file
JGJie Gao
Jie Gao
XLXiyu Li
Xiyu Li
GZGuohua Zhang
Guohua Zhang
FSFaizan Ahmed Sadiq
Faizan Ahmed Sadiq
JSJesus Simal‐Gandara
Jesus Simal‐Gandara
YSYaxin Sang
Yaxin Sang
The past two decades have witnessed a global surge in the application of probiotics as functional ingredients in food, animal feed, and pharmaceutical products. Among food industries, the dairy industry is the largest sector where probiotics are employed in a number of dairy products including sour/fermented milk, yogurt, cheese, butter/cream, ice cream, and infant formula. These probiotics are either used as starter culture alone or in combination with traditional starters, or incorporated into dairy products following fermentation, where their presence imparts many functional characteristics to the product (for instance, improved aroma, taste, and textural characteristics), in addition to conferring many health‐promoting properties. However, there are still many challenges related to the stability and functionality of probiotics in dairy products. This review highlights the advances, opportunities, and challenges of application of probiotics in dairy industries. Benefits imparted by probiotics to dairy products including their role in physicochemical characteristics and nutritional properties (clinical and functional perspective) are also discussed. We transcend the traditional concept of the application of probiotics in dairy products and discuss paraprobiotics and postbiotics as a newly emerged concept in the field of probiotics in a particular relation to the dairy industry. Some potential applications of paraprobiotics and postbiotics in dairy products as functional ingredients for the development of functional dairy products with health‐promoting properties are briefly elucidated.

7 June 2022 in LWT
Verified
Journal Article
Open access
TZTongxin Zhi
Tongxin Zhi
XLXiyu Li
Xiyu Li
FSFaizan Ahmed Sadiq
Faizan Ahmed Sadiq
KMKemin Mao
Kemin Mao
JGJie Gao
Jie Gao
YSYaxin Sang
Yaxin Sang

18 January 2024 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
TZTuo Zhang
Tuo Zhang
TCTiantian Cheng
Tiantian Cheng
SGShuo Geng
Shuo Geng
KMKemin Mao
Kemin Mao
XLXiyu Li
Xiyu Li
YSYaxin Sang
Yaxin Sang

1 January 2019 in CyTA - Journal of Food
Verified
Journal Article
Open access
CZChang Zhou
Chang Zhou
JLJiao Li
Jiao Li
KMKemin Mao
Kemin Mao
JGJie Gao
Jie Gao
XLXiyu Li
Xiyu Li
YSYaxin Sang
Yaxin Sang
This study aimed to develop and characterize a fermented persimmon juice with potential anti-hangover and anti-hypertensive effects using gamma-aminobutyric acid (GABA)-producing lactic acid bacteria. Results showed the co-fermentation of Lactobacillus plantarum C17 and Lactobacillus pentosus Lp-B produced the highest yield of 2.102 mmol/L of GABA. After 48 h of fermentation, GABA was produced at the conversion rate of 69.32% from glutamate. The alcohol dehydrogenase activation rate, acetaldehyde dehydrogenase activation activity and hydroxyl inhibition rate of fermented persimmon juice were 38.91%, 34.72%, and 16.79%, respectively, which displayed higher anti-hangover activity compared to unfermented persimmon. Moreover, the angiotensin-converting enzyme inhibition ability of fermented persimmon juice was 42.34% and the expression level of human endothelin-1 was reduced to 34.64 μg/mL. These findings indicated GABA-enriched fermented persimmon juice had potential anti-hangover and anti-hypertensive properties.

26 August 2025 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Open access
XLXiyu Li
Xiyu Li
SWSebastiaan Wesseling
Sebastiaan Wesseling
YSYaxin Sang
Yaxin Sang
IRIvonne M.C.M. Rietjens
Ivonne M.C.M. Rietjens
Food-borne advanced glycation end-products could potentially contribute to the endogenous AGE accumulation within the body, albeit to a different extent for different AGEs. This study focuses on characterizing intestinal absorption and intracellular accumulation of 10 selected free low-molecular-mass (LMM) advanced glycation end-products (AGEs) to obtain insight into potential differences in their systemic bioavailability by using a Caco-2 transwell model. The findings reveal that all tested AGEs can cross the intestinal barrier through the paracellular route, albeit to a limited extent. Glycolic acid-lysine-amide (GALA) shows the highest transport percentage, reaching 1.1% ± 0.3% after 2 h, while N-ε-(carboxymethyl)lysine (CML) displays the highest level of accumulation in intestinal cells, reaching 3.5% ± 0.6%. In contrast, cross-linked AGEs appeared to be hardly absorbed or accumulating. Passive transport likely dominates the intestinal uptake of LMM AGEs, with quantitative structure activity relationships based on maximum projection area and molar refractivity or on maximum projection area and molecular mass best describing their uptake rate. This study provides novel insights into differences in bioavailability and intracellular accumulation of LMM AGEs and the potential for fingerprinting their intestinal transport by a new approach methodology.

6 October 2024 in npj Science of Food
Verified
Journal Article
Open access
PDF file
Liang ZhengLiang Zheng
Liang Zheng
XLXiyu Li
Xiyu Li
FWFrances Widjaja
Frances Widjaja
CLChen Liu
Chen Liu
IRIvonne M. C. M. Rietjens
Ivonne M. C. M. Rietjens
This study aimed to evaluate human neurotoxicity and genotoxicity risks from dietary and endogenous methylglyoxal (MGO), utilizing physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry as a new approach methodology (NAM) to extrapolate in vitro toxicity data to in vivo dose-response predictions. A human PBK model was defined based on a newly developed and evaluated mouse model enabling the translation of in vitro toxicity data for MGO from human stem cell-derived neurons and WM-266-4 melanoma cells into quantitative human in vivo toxicity data and subsequent risk assessment by the margin of exposure (MOE) approach. The results show that the MOEs resulting from daily dietary intake did not raise a concern for endpoints for neurotoxicity including mitochondrial function, cytotoxicity, and apoptosis, while those for DNA adduct formation could not exclude a concern over genotoxicity. Endogenous MGO formation, especially under diabetic conditions, resulted in MOEs that raised concern not only for genotoxicity but also for some of the neurotoxicity endpoints evaluated. Thus, the results also point to the importance of taking the endogenous levels into account in the risk assessment of MGO.